Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleNeurology

Reshaping the Amyloid Buildup Curve in Alzheimer Disease? Partial-Volume Effect Correction of Longitudinal Amyloid PET Data

Michael Rullmann, Anke McLeod, Michel J. Grothe, Osama Sabri and Henryk Barthel; the Alzheimer’s Disease Neuroimaging Initiative
Journal of Nuclear Medicine December 2020, 61 (12) 1820-1824; DOI: https://doi.org/10.2967/jnumed.119.238477
Michael Rullmann
1Department of Nuclear Medicine, University of Leipzig, Leipzig, Germany; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anke McLeod
1Department of Nuclear Medicine, University of Leipzig, Leipzig, Germany; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michel J. Grothe
2German Center for Neurodegenerative Diseases–Rostock/Greifswald, Rostock, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Osama Sabri
1Department of Nuclear Medicine, University of Leipzig, Leipzig, Germany; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Henryk Barthel
1Department of Nuclear Medicine, University of Leipzig, Leipzig, Germany; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 61 no. 12 1820-1824
DOI 
https://doi.org/10.2967/jnumed.119.238477
PubMed 
32358089

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication October 21, 2019
  • Accepted for publication March 28, 2020
  • Published online December 1, 2020.

Article Versions

  • previous version (May 1, 2020 - 11:16).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2020 by the Society of Nuclear Medicine and Molecular Imaging.

Author Information

  1. Michael Rullmann1,
  2. Anke McLeod1,
  3. Michel J. Grothe2,
  4. Osama Sabri1 and
  5. Henryk Barthel1 the Alzheimer’s Disease Neuroimaging Initiative
  1. 1Department of Nuclear Medicine, University of Leipzig, Leipzig, Germany; and
  2. 2German Center for Neurodegenerative Diseases–Rostock/Greifswald, Rostock, Germany
  1. For correspondence or reprints contact: Michael Rullmann, Department of Nuclear Medicine, University of Leipzig, Liebigstrasse 18, D-04103 Leipzig, Germany.
  2. E-mail: rullmann{at}medizin.uni-leipzig.de
View Full Text

Statistics from Altmetric.com

Cited By...

  • 6 Citations
  • 8 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Comparing the Clinical Utility and Diagnostic Performance of CSF P-Tau181, P-Tau217, and P-Tau231 Assays
    Antoine Leuzy, Shorena Janelidze, Niklas Mattsson-Carlgren, Sebastian Palmqvist, Dirk Jacobs, Claudia Cicognola, Erik Stomrud, Eugeen Vanmechelen, Jeffrey L. Dage, Oskar Hansson
    Neurology 2021 97 17
  • International Nuclear Medicine Consensus on the Clinical Use of Amyloid Positron Emission Tomography in Alzheimer’s Disease
    Mei Tian, Chuantao Zuo, Ali Cahid Civelek, Ignasi Carrio, Yasuyoshi Watanabe, Keon Wook Kang, Koji Murakami, Valentina Garibotto, John O. Prior, Henryk Barthel, Yihui Guan, Jiaying Lu, Rui Zhou, Chentao Jin, Shuang Wu, Xiaohui Zhang, Yan Zhong, Hong Zhang
    Phenomics 2023 3 4
  • PET Agents in Dementia: An Overview
    Aren van Waarde, Sofia Marcolini, Peter Paul de Deyn, Rudi A.J.O. Dierckx
    Seminars in Nuclear Medicine 2021 51 3
  • Longitudinal amyloid and tau PET imaging in Alzheimer's disease: A systematic review of methodologies and factors affecting quantification
    Ariane Bollack, Hugh G. Pemberton, Lyduine E. Collij, Pawel Markiewicz, David M. Cash, Gill Farrar, Frederik Barkhof
    Alzheimer's & Dementia 2023 19 11
  • Focal amyloid and asymmetric tau in an imaging-to-autopsy case of clinical primary progressive aphasia with Alzheimer disease neuropathology
    Adam Martersteck, Ivan Ayala, Daniel T. Ohm, Callen Spencer, Christina Coventry, Sandra Weintraub, Eileen H. Bigio, M. -Marsel Mesulam, Changiz Geula, Emily Rogalski
    Acta Neuropathologica Communications 2022 10 1
  • Impact of Partial Volume Correction on [18F]GE-180 PET Quantification in Subcortical Brain Regions of Patients with Corticobasal Syndrome
    Sebastian Schuster, Leonie Beyer, Carla Palleis, Stefanie Harris, Julia Schmitt, Endy Weidinger, Catharina Prix, Kai Bötzel, Adrian Danek, Boris-Stephan Rauchmann, Sophia Stöcklein, Simon Lindner, Marcus Unterrainer, Nathalie L. Albert, Lena M. Mittlmeier, Christian Wetzel, Rainer Rupprecht, Axel Rominger, Peter Bartenstein, Robert Perneczky, Johannes Levin, Günter U. Höglinger, Matthias Brendel, Franziska J. Dekorsy
    Brain Sciences 2022 12 2
  • Trajectories of amyloid beta accumulation – Unveiling the relationship with APOE genotype and cognitive decline
    Maha Wybitul, Andreas Buchmann, Nicolas Langer, Christoph Hock, Valerie Treyer, Anton Gietl
    Neurobiology of Aging 2024 139
  • Molecular Imaging of Neurodegenerative Disorders
    Ciprian Catana
    2023

Article usage

Article usage: May 2020 to April 2025

AbstractFullPdf
May 2020506044
Jun 2020111012
Jul 20206201
Aug 202078011
Sep 20205006
Oct 20207104
Nov 202068015
Dec 20208492078
Jan 20211811321
Feb 20211921121
Mar 2021127913
Apr 2021144712
May 202169411
Jun 2021452112
Jul 2021252618
Aug 2021152023
Sep 2021212819
Oct 2021132230
Nov 2021162624
Dec 2021252813
Jan 2022251911
Feb 202215167
Mar 202215149
Apr 2022141912
May 2022171715
Jun 2022111110
Jul 202283713
Aug 20229188
Sep 202261312
Oct 20229126
Nov 20224149
Dec 20228163
Jan 202361513
Feb 20236279
Mar 20238168
Apr 20232108
May 2023455
Jun 20236127
Jul 2023569
Aug 2023101012
Sep 202381610
Oct 202311168
Nov 202322239
Dec 202310177
Jan 202411235
Feb 2024771
Mar 202472440
Apr 202473115
May 20244536
Jun 20246198
Jul 2024161616
Aug 2024273124
Sep 2024353023
Oct 2024101113
Nov 202471312
Dec 202410345
Jan 202531311
Feb 2025127213
Mar 202594118
Apr 202556322
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 61 (12)
Journal of Nuclear Medicine
Vol. 61, Issue 12
December 1, 2020
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Reshaping the Amyloid Buildup Curve in Alzheimer Disease? Partial-Volume Effect Correction of Longitudinal Amyloid PET Data
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Reshaping the Amyloid Buildup Curve in Alzheimer Disease? Partial-Volume Effect Correction of Longitudinal Amyloid PET Data
Michael Rullmann, Anke McLeod, Michel J. Grothe, Osama Sabri, Henryk Barthel
Journal of Nuclear Medicine Dec 2020, 61 (12) 1820-1824; DOI: 10.2967/jnumed.119.238477

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Reshaping the Amyloid Buildup Curve in Alzheimer Disease? Partial-Volume Effect Correction of Longitudinal Amyloid PET Data
Michael Rullmann, Anke McLeod, Michel J. Grothe, Osama Sabri, Henryk Barthel
Journal of Nuclear Medicine Dec 2020, 61 (12) 1820-1824; DOI: 10.2967/jnumed.119.238477
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Visual Abstract
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • Comparing the Clinical Utility and Diagnostic Performance of CSF P-Tau181, P-Tau217, and P-Tau231 Assays
  • Google Scholar

More in this TOC Section

Neurology

  • Dopamine D1 Receptor Agonist PET Tracer Development: Assessment in Nonhuman Primates
  • Hypermetabolism on Pediatric PET Scans of Brain Glucose Metabolism: What Does It Signify?
  • TauIQ: A Canonical Image Based Algorithm to Quantify Tau PET Scans
Show more Neurology

Clinical

  • Addition of 131I-MIBG to PRRT (90Y-DOTATOC) for Personalized Treatment of Selected Patients with Neuroendocrine Tumors
  • SUVs Are Adequate Measures of Lesional 18F-DCFPyL Uptake in Patients with Low Prostate Cancer Disease Burden
  • Hypermetabolism on Pediatric PET Scans of Brain Glucose Metabolism: What Does It Signify?
Show more Clinical

Similar Articles

Keywords

  • PET
  • amyloid
  • longitudinal
  • partial-volume effect correction
SNMMI

© 2025 SNMMI

Powered by HighWire